Orthometrix, Inc. (OMRX)
ValueMarkers Composite Index
DCF data not available
Orthometrix, Inc. (OMRX) — VMCI valuation read
OMRX prints VMCI 65/100 inside the Healthcare sector, where the median sits at 50. The 15-point above-median delta is the cleanest single-number summary of Orthometrix, Inc.'s composite stance, and in the mid-cap bucket it places the share ahead of the typical peer on the five-pillar mix.
On OMRX, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.
**Investor frame.** OMRX trades at 26.0x earnings, 44% above the Healthcare median of 18.0x; that is the value line. ROIC of 14.0% sits 4.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of -1.6x leaves covenant headroom; that is the risk line for Orthometrix, Inc. on the trailing financials.
OMRX fell 2.0% over the trailing 7 days, with a -8.3% read on a 30-day basis.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.